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Abstract
Background: Mutations and gene expression alterations in brain tumors have been extensively
investigated, however the causes of brain tumorigenesis are largely unknown. Animal models are
necessary to correlate altered transcriptional activity and tumor phenotype and to better
understand how these alterations cause malignant growth. In order to gain insights into the in vivo
transcriptional activity associated with a brain tumor, we carried out genome-wide microarray
expression analyses of an adult brain tumor in Drosophila caused by homozygous mutation in the
tumor suppressor gene brain tumor (brat).
Results: Two independent genome-wide gene expression studies using two different
oligonucleotide microarray platforms were used to compare the transcriptome of adult wildtype
flies with mutants displaying the adult bratk06028 mutant brain tumor. Cross-validation and stringent
statistical criteria identified a core transcriptional signature of bratk06028 neoplastic tissue. We find
significant expression level changes for 321 annotated genes associated with the adult neoplastic
bratk06028 tissue indicating elevated and aberrant metabolic and cell cycle activity, upregulation of
the basal transcriptional machinery, as well as elevated and aberrant activity of ribosome synthesis
and translation control. One fifth of these genes show homology to known mammalian genes
involved in cancer formation.
Conclusion: Our results identify for the first time the genome-wide transcriptional alterations
associated with an adult brain tumor in Drosophila and reveal insights into the possible mechanisms
of tumor formation caused by homozygous mutation of the translational repressor brat.
Background
Cancer is a multistep process, which involves loss of cell
proliferation control, resistance to cell death, and inva-
sion as well as metastasis. This process is often associated
with multiple and progressive genetic alterations. Proto-
oncogenes are activated in a dominant fashion by muta-
tion, chromosome translocation or gene amplification,
whereas tumor suppressor genes are inactivated or lost by
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gene conversion [1-3].
Mutations and gene expression alterations in brain
tumors have been extensively investigated. For example,
data has been accumulated for the cerebellar tumor
medulloblastoma which is the most common malignant
brain tumor in children [4]. In addition to chromosome
loss, medulloblastomas overexpress certain genes, includ-
ing c-myc, pax5, and zic, all of which encode transcription
factors [5-7]. Thus, animal models of brain tumors are
required to gain insights into the correlation of genetic
alterations and tumor phenotype and to better under-
stand how genetic alterations cause malignant neoplasm
[4,8]. To better understand the genetic alterations associ-
ated with brain tumors in vivo, the fruitfly Drosophila mel-
anogaster is an excellent model system for which
unprecedented genetic and transgenic technologies as
well as entire genome sequence information are available
[9,10]. Indeed, more than two thirds of the known human
cancer genes are thought to have Drosophila homologs
[11,12], and various studies have shown that genetic inac-
tivation or misregulation of Drosophila oncogenes or
tumor suppressor genes lead to neoplasms that display
characteristic features of malignant growth like in human
cancer [13-15]. The level of gene and pathway conserva-
tion, the similarity of cellular processes, and the emerging
evidence of functional conservation of Drosophila genes
that are homologous to mammalian oncogenes or tumor
suppressor genes, indicate that studies of tumorigenesis in
flies can directly contribute to the understanding of
human brain tumors [16,17].
One of the earlier studies on mutations causing malignant
neoplasms in Drosophila examined 12 recessive lethal
mutations affecting the optic neuroblasts and ganglion
mother cells in the larval brain, the imaginal discs, and the
hematopoietic organs [13]. Among others, it could be
shown, that a mutation in the lethal (2) giant larvae (lgl)
gene leads to a failure of the optic neuroblasts of the inner
and outer formation centers and the ganglion mother cells
(GMCs) to generate adult neurons. The neuroblasts and
GMCs proliferated extensively, causing a dramatic
enlargement of the larval brain hemispheres. Upon trans-
plantation of neoplastic tissue into wildtype hosts, the
transplanted tissues invaded the body cavities, the abdo-
men, the thorax, the ovaries, the gut, and the thoracic
muscles [13].
Further investigation of mutations in the dlg1 and lgl
genes revealed that the resulting phenotypes exhibited
most of the characteristics defining neoplastic growth in
vertebrates, including rapid growth both in situ and in
culture, defective intercellular junctions, low adhesiveness
in between cells, defective intercellular communication,
absence of terminal differentiation, lack of response to
ecdysone, invasiveness, and lethality to the host ([13],
reviewed in [18]).
Furthermore, it is known that expression of an activated
form of RAS1 (RAS1V12) in Drosophila imaginal discs is
leading to ectopic cell proliferation and hyperplastic tis-
sue growth [19]. The mutational activation of the human
homolog of Ras is associated with a wide variety of
human tumors (reviewed in [20]). When RASV12 expres-
sion is combined with inactivation of scribbled. (scrib),
lethal (2) giant larvae (lgl), discs large 1 (dlg1), bazooka
(baz), stardust(sdt) and Cdc42 in Drosophila larvae, migra-
tion, invasion of tumor tissue and secondary tumor foun-
dation can be found [15]. Another Drosophila gene
possessing tumor suppressor properties is warts (wts). Flies
homozygous for strong wts alleles show overproliferation
in the imaginal discs and the central nervous system lead-
ing to pupal lethality. The observed cellular clones where
irregular in shape, unpatterned and formed folded lobes.
The cells to be found in wts mutant clones were larger than
neighboring wildtype cells [21]. The mammalian
homolog of wts, LATS1, is also known for causing soft-tis-
sue sarcomas and ovarian stromal cell tumors when
mutated in mice [22]. The current model of wts / LATS1
function suggests interaction with CyclinA / Cdc2, linking
it directly to the cell cycle ([23], reviewed in [24]).
Mutations in the Drosophila gene salvador (sav) have been
associated with increased cell growth and an increase in
cell number. Also, Sav has been suggested to interact
directly with Wts and thereby contributing to its function
[25].
In this report, we have determined at the full genome level
the transcriptional signature of an adult brain tumor in
Drosophila caused by homozygous mutation in the tumor
suppressor gene brain tumor (brat). This gene encodes a
member of the conserved NHL family of proteins, which
appear to regulate differentiation and growth. These fac-
tors have been directly implicated in human tumor for-
mation [26,27]. Based on the analysis of loss- and gain-of-
function experiments, Brat acts in translation repression,
ribosomal RNA synthesis, and negative regulation of cell
growth [28-30]. Structural analysis indicates that the NHL
beta-propeller is the essential domain for both the trans-
lational repression and cell growth inhibitory activities of
Brat [31]. Inactivation of brat results in neoplastic over-
growth and tumor formation in the larval brain and gen-
erally causes lethality in the larval third instar and pupal
stages [32]. It has been hypothesized that in brat loss-of-
function larvae the optic neuroblasts and ganglion
mother cells are incapable of generating neurons and
repesent the source of the brain tumor [33]. Tumor cells
derived from homozygous brat larval brain tissue canPage 2 of 22
(page number not for citation purposes)
BMC Genomics 2004, 5 http://www.biomedcentral.com/1471-2164/5/24grow not only in situ, but also after transplantation into
adult host flies. The transplanted cells grow rapidly, form-
ing metastases and secondary malignant tumors, and
finally kill their host [34].
Here we focus on the strong neoplastic adult brain pheno-
type caused by homozygous mutation of the bratk06028
allele. To analyze the transcriptional activity associated
with this brain tumor, we carried out two independent
genome-wide microarray expression studies using two dif-
ferent oligonucleotide array platforms to compare adult
wildtype flies with flies displaying the adult bratk06028
mutant brain tumor. Our experiments identified 321
annotated genes that showed highly significant
(p<=0.0001) changes in expression levels due to loss of
the tumor suppressor activity of brat. One fifth of these
genes show homology to known mammalian genes
involved in cancer formation. We observed significant
upregulation of genes involved in the control of asymmet-
ric neuroblast division. We also found significant upregu-
lation of genes involved in ribosome biogenesis,
translation, and RNA processing, suggesting a link
between the tumor suppressor activity of brat and its role
as a translational repressor during Drosophila develop-
ment.
Results
Adult homozygous bratk06028 mutants show a strong 
neoplastic brain phenotype
The brat mutant allele bratk06028 was generated by a Plac W
transposon insertion in the non-coding Exon 4 of the brat
locus lying immediately upstream of the transcriptional
start site [28,32]. Larvae homozygous for this insertion
manifest a strong neoplastic brain phenotype. We found
that 15% (n = 979) of homozygous bratk06028 mutants
eclose. These homozygous adult bratk06028 mutants show
limited motility compared to Oregon R wildtype flies and
their lifespan is strongly reduced; most of the
homozygous bratk06028 mutants die after the first 10 days.
Histological analysis showed that homozygous adult
bratk06028 mutants display a pronounced overproliferation
in their brains as compared to Oregon R wildtype brains
(Figure 1). The penetrance of this phenotype is 100% (n =
300). Most of the newly hatched bratk06028 mutants
showed a head capsule completely filled with neoplastic
tissue. In addition, we observed ectopic neuropil-like
structures; these structures appeared bilaterally in ventro-
medial positions dorsal to the central brain complex and
more ventro-laterally to the optic lobes (Figure 1B, arrow-
heads). In paraffin sections the size of the central brain
structures and the optic lobes of bratk06028 mutants
appeared reduced as compared to the wildtype, however,
the overall morphology of neuropil subdivisions in these
brains was retained.
Transcriptional signature of the adult bratk06028 mutant 
brain tumor
In order to gain insights into the genetic alterations asso-
ciated with a fully developed brain tumor in vivo, we deter-
mined at the full genome level the transcriptome of the
neoplastic brain tumors caused by homozygous bratk06028
mutation as compared to wildtype brain. To ensure cross-
validation and increased significance of our results, we
conducted two independent genome-wide gene expres-
sion studies to compare wildtype flies with homozygous
bratk06028 flies using two different oligonucleotide array
platforms (Table 1). In the first experiment, RNA was
Adult flies homozygous for the bratk06028 allele show a strong neoplastic brain phenotypeFigure 1
Adult flies homozygous for the bratk06028 allele show a strong 
neoplastic brain phenotype. Horizontal 7 µm paraffin sec-
tions at the level of the oesophagus (oe) of the heads of two 
days old adult Oregon R wildtype (A) and bratk06028 (B) flies. 
Homozygous adult bratk06028 mutants display a pronounced 
neoplastic phenotype in their heads (B, arrow) and ectopic 
neuropil-like structures can be observed (B, arrowheads). 
The size of several neuropil structures like lamina (la), 
medulla (me), lobula (lo), lobula plate (lp), antennal lobe (al), 
and ventrolateral protocerebrum (vp) appears reduced (B, 
compare to wildtype in A). However, their overall morphol-
ogy appears to be unaffected, suggesting that the cells giving 
rise to these neuropil structures differentiated normally in 
homozygous adult bratk06028 mutants.Page 3 of 22
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from isolated adult fly heads of Oregon R as control. The
labeled cRNA of this experiment was hybridized to cus-
tom made full-genome GeneChips (roDROMEGa, exper-
iment A). In the second experiment, RNA was extracted
from dissected adult brains, and hybridization of labeled
cRNA to commercially available full-genome Gene Chips
involved a signal amplification step (DrosGenome1,
experiment B; see materials and methods). Moreover, in
this second experiment, the transcriptome of dissected
adult brains of homozygous bratk06028 mutants was com-
pared to dissected adult brains of flies generated by trans-
poson excision of the bratk06028 P-element (termed
bratk06028 jumpout, see materials and methods). Precise
transposon excision resulted in reversion of the bratk06028
neoplastic brain phenotype to wildtype-like brain (data
not shown).
Stringent quality control and filtering for the two resulting
data sets was done independently (see materials and
methods). After analysis, 1778 transcripts in the wildtype
condition and 2955 transcripts in the bratk06028 condition
of experiment A were statistically judged as present. This
represents 12.7% and 21% of all transcripts on the
roDROMEGa array, respectively. In experiment B, 5063
transcripts were judged as present in the wildtype-like
bratk06028 jumpout condition and 4981 in the bratk06028 con-
dition. This represents 36.3% and 35.7% of all transcripts
on the DrosGenome1 array, respectively. Transcripts in
both datasets were considered as differentially expressed
when the change between conditions was larger than 2-
fold, their signal strength was above 10 in the condition
with the higher expression level, and the change had a sig-
nificance value of p ≤ 0.0001 (t-test). In experiment A 725
transcripts were judged as differentially expressed,
whereas in experiment B 1888 transcripts were judged as
differentially expressed in the bratk06028 tumor condition
(Table 1).
The core set of genes differentially expressed in bratk06028 
neoplasms
To strengthen the significance of our data, we considered
those genes for further analysis that passed the filter
criteria in both experiments. This was the case for 321
transcripts, representing a core transcriptional signature
that characterizes the neoplastic tissue of adult
homozygous bratk06028 mutants in a highly reproducible
manner (Table 1). In both experiments, the majority of
the 321 differentially regulated genes (279) showed an
increased expression level in neoplastic adult bratk06028
mutants. 42 transcripts out of 321 differentially regulated
genes showed a decreased expression level in the bratk06028
condition. (5 transcripts out of the 321 genes showed an
opposite differential expression change in experiment A
and B). As shown in Figure 2, the majority of the 321
genes differentially regulated in bratk06028 neoplasms dis-
played comparable expression level changes in both
experiments. Only 88 genes showed significantly higher
expression level changes in experiment B as compared to
experiment A. This may be due to the fact that in experi-
ment B cRNA hybridization to the array involved a signal
amplification step (see materials and methods).
Table 1: Overview of the array experiments
Experiment A Experiment B
RNA source brat tumor adult brat[k06028] heads adult brat[k06028] brains
control Oregon RS heads brat[k06028] jumpout brains
Arrays used roDromega full genome Affymetrix full genome
Number of replicates 5 Oregon RS against 6 brat[k06028] 6 brat[k06028] jumpout against 6 brat [k06028]
Signal amplification no yes
Differentially expressed genes 725 1888
Overlap between the experiments 321
Overview of the two independent genome-wide gene expression studies using two different oligonucleotide array platforms to compare adult 
control flies with flies displaying the adult bratk06028 mutant brain tumor. Row 1 and Row2 indicate the source from which total RNA was extracted. 
Row 1 indicates source of tumor tissue, Row 2 indicates source of control tissue used in the experiments. For experiment A (left column), total 
RNA was isolated from homozygous bratk06028 mutant heads (row 1) as compared to total RNA isolated from Oregon R wildtype heads (row 2). 
For experiment B (right column), total RNA was isolated from dissected homozygous bratk06028 mutant brains (row 1) as compared to total RNA 
isolated from dissected brains derived from flies generated by transposon excision of the bratk06028 P-element (termed A2, bratk06028 jumpout; row 
2). Row 3 denotes the two different Affymetrix oligonucelotide arrays used. Row 4 indicates the number of replicates carried out per condition for 
experiment A and experiment B, respectively. Row 5 displays whether or not a signal amplification step has been performed following cRNA 
hybridization to the arrays. Row 6 presents the number of transcripts differentially expressed between conditions for experiment A and 
experiment B, respectively. Row 7 indicates the number of genes that passed the filter criteria in both experiments.Page 4 of 22
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ments were grouped into functional classes according to
their annotation in Flybase. The function of most of the
differentially expressed transcripts were unknown (n =
67). A list of these genes is shown in Figure 8. The remain-
ing genes of known function were grouped into the func-
tional classes metabolism (n = 56), cytoskeleton/structural
proteins (n = 31), RNA binding/processing (n = 27), transcrip-
tion/replication/repair (n = 20), translation (n = 19), cell cycle
(n = 18), transcriptional regulation (n = 17) chromatin struc-
ture (n = 13), signal transduction (n = 12), chaperones (n =
11), transport (n = 10), proteolytic systems (n = 8), stress
response (n = 7), cell surface receptors/CAMs/ion channels (n
= 4), and apoptosis (n = 1). You can find a list of these 321
genes along with the fold change between experiments in
Supplementary Table 3 [see Additional file 3].
Genes involved in metabolism, cell cycle and apoptosis
Neoplastic overgrowth involves essential alterations in
cell physiology, loss of cell proliferation control and
resistance to cell death. Accordingly, we expected to
observe the differential expression of genes linked to
metabolism, cell cycle regulation and apoptosis in our
gene expression profile studies. Indeed, transcript
profiling of bratk06028 mutants identified transcripts of this
type of which misregulation appears to be associated with
malignant growth.
Expression level changes observed for the 321 genes identified in both oligonucleotide array experiments as differentially regu-lated in the brat tumor conditionFigure 2
Expression level changes observed for the 321 genes identified in both oligonucleotide array experiments as differentially regu-
lated in the brat tumor condition. X-coordinate shows relative fold-changes for each individual gene (y-coordinate) depicted in 
red for experiment A and depicted in orange for experiment B, respectively. Note that the two experiments A and B disagree 
on the differential expression level changes only for five transcripts. Please note that the highest expression levels are cut at a 
value of 80 due to the scaling of the y-axis.
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BMC Genomics 2004, 5 http://www.biomedcentral.com/1471-2164/5/24Differential expression of genes belonging to the functional classes metabolism, cell cycle and apoptosisFigu  3
Differential expression of genes belonging to the functional classes metabolism, cell cycle and apoptosis. Fold-changes for each 
gene are shown in red for experiment A and in orange for experiment B, respectively.
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transcripts with elevated expression levels (Figure 3).
These genes included eyes absent (eya), whose activity is
required for the survival of progenitor cells at a critical
stage in eye morphogenesis [35] as well as uninitiated
(und), the Drosophila methionine aminopeptidase 2,
which was shown to be a putative regulator of translation
initiation required for cell growth and patterning [36]. We
also detected selenide, water dikinase (SelD) as differen-
tially upregulated in bratk06028 neoplasms. SelD encodes a
product involved in selenocysteine biosynthesis, and
mutational inactivation in SelD results in a reduction in
cell proliferation in the imaginal discs and the larval brain
[37]. Within the functional class metabolism, we also
found 15 transcripts as significantly down-regulated in
the bratk06028 tumor condition (Figure 3). Among these
were bubblegum (bgm), encoding a product with long-
chain-fatty-acid-CoA-ligase activity. Mutant analysis of
bgm revealed that in young homozygous mutant flies the
optic lobes appear normal however as the flies grow older
the optic lobes show signs of regional degeneration [38].
As expected, all of the transcripts positively regulating cell
cycle showed increased expression levels in the tumor
condition as compared to the wildtype situation. Among
these we identified cyclin A, cyclin B, cyclin E, string (stg),
cdc2, Cdk7, Cks, Set, abnormal spindle (asp), fizzy (fzy), polo,
and Myb oncogene-like (Myb). These genes are involved in
the regulation of highly conserved aspects of cell prolifer-
ation such as progression through G1, S and G2/M
phases, spindle orientation and the maintenance of
genomic integrity throughout mitosis.
Of particular interest is the highly significant upregulation
of the genes asp, fzy, rough deal (rod), and Myb. asp encodes
a microtubule-associated protein that associates with the
polar regions of the mitotic spindle. Mutants of asp are lar-
val lethal, with a high frequency of aberrant (e.g. poly-
ploid) cells arrested in metaphase in the larval brain,
suggesting that asp may play a role in spindle pole organ-
ization during mitosis [39]. fzy encodes a product
involved in cyclin catabolism and fzy mutants also show
metaphase arrest with compact condensed chromosomes
like asp mutants [40]. rod encodes a product involved in
mitotic chromosome segregation which is localised to the
kinetochore, and mutations in rod result in mitotic segre-
gational failure due to delayed or incomplete release of
sister chromatids [41]. Finally Myb encodes a proto-onco-
gene with transcriptional activator activity involved in
centrosome cycle which is required to sustain the appro-
priate rate of proliferation, to suppress formation of
supernumerary centrosomes, and to maintain genomic
integrity [42].
It is noteworthy that the activity of all of these genes
involved in cell cycle regulation has been linked to several
aspects of neurogenesis [43,44]. Thus, all of these genes
are known to be expressed during embryonic and larval
development in mitotically active cells of the nervous sys-
tem, the neuroblasts and ganglion mother cells (GMCs),
suggesting that their elevated levels of transcriptional
activity correlate with an elevated and aberrant activity of
the cell cycle machinery in neoplasms of homozygous
bratk06028 mutants.
We did not detect any significant alteration of gene expres-
sion concerning transcripts belonging to the functional
class apoptosis, except elevated expression levels for thiore-
doxin peroxidase 2 (Jafrac2), which is involved in the induc-
tion of apoptosis [45]. The fact that we only identified one
transcript involved in programmed cell death suggests
that the apoptotic program is either impaired below
detectability or is unaltered in neoplastic tissue of adult
bratk06028 mutant brain tumors.
Genes involved in translation and RNA binding/processing
Recent studies have shown that brat acts as a translational
repressor [29]. Moreover, mutant analyses demonstrated
that brat-mutant cells are larger than wildtype cells and
have enlarged nucleoli, which are associated with an
increase in total rRNA production. Also, the C. elegans
homolog of brat, ncl-1, is known for being a repressor of
RNA polymerase I and III transcription and for being an
inhibitor of cell growth. Loss of function mutations in ncl-
1, result in enlarged nucleoli. The rates of rRNA and 5S
RNA transcription are increased and cells are enlarged.
[46]. These data suggest that excess ribosomal synthesis
and cell growth may be important aspects of the tumorous
phenotype of bratk06028 mutants [30]. Indeed, in addition
to an elevated and aberrant activity of the cell cycle
machinery, our gene expression profile of bratk06028 adult
brain tumors detected genes involved in all aspects of
ribosome synthesis and translation control. Thus, tran-
script profiling of bratk06028 mutants identified 19 tran-
scripts as differentially expressed belonging to the
functional class translation and 27 transcripts as differen-
tially expressed in the functional class RNA binding/
processing. All of these transcripts showed increased
expression level in the tumor condition as compared to
the wildtype situation (Figure 4).
Among the transcripts that belong to the functional class
translation we identified Eukaryotic initiation factor 1A (eIF-
1A), Eukaryotic initiation factor 3 p40 subunit (eIF-3p40),
and Int6 homologue (Int6) that encode proteins with trans-
lation initiation factor activity involved in protein
biosynthesis [47]. Moreover, genes involved in translation
elongation factor activity like Elongation factor 1α48D
(Ef1α48), Ef1γ, and eEF1δ were detected as significantlyPage 7 of 22
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involved in 35S primary transcript processing (Fibrillarin,
Fib) and in rRNA processing (Nop5) were identified as
upregulated. Interestingly, we also detected upregulation
of Ribosomal protein L1 (RpL) and Ribosomal protein L3
(RpL3), both of which encode structural constituent of the
ribosome involved in protein biosynthesis. RpL3 is of par-
ticular interest as it has been mapped to the chromosomal
region harbouring the Minute(3) 86D mutation [48].
Among the transcripts that belong to the functional class
RNA binding/processing we identified Rrp4 and Csl4, both
encoding gene products with 3'-5' exoribonuclease activ-
ity involved in mRNA processing [49]. Also Developmental
embryonic B (DebB) and SC35 with pre-mRNA splicing fac-
tor activity involved in mRNA splicing were detected as
significantly upregulated [50]. In addition, Rm62 encod-
ing a product with ATP dependent RNA helicase activity
involved in RNA interference was upregulated in the
tumor condition, as were U2 small nuclear riboprotein aux-
iliary factor 50 (U2af50) and U2 small nuclear riboprotein
auxiliary factor 38 (U2af38), both encoding products with
pre-mRNA splicing factor activity involved in mRNA splic-
ing (reviewed in [47]). Within this functional class we also
identified upregulated transcripts which are involved in
various aspects of cell growth and proliferation, such as
polyA-binding protein (pAbp) which encodes a product with
poly(A) binding involved in positive regulation of trans-
lation. pAbp mutants display cytokinesis defects, and
mutant analyses demonstrated that pAbp is required to
connect the centrosome to the minus-ends of free
microtubules (reviewed in [47]). Intriguingly, we also
detected Small ribonucleoprotein Sm D3 (SmD3), which
encodes a protein involved in mRNA splicing, as upregu-
Differential expression of genes belonging to the functional classes translation and RNA binding / processingFigu  4
Differential expression of genes belonging to the functional classes translation and RNA binding / processing. Fold-changes for 
each individual gene are shown in red for experiment A and in orange for experiment B, respectively.
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interest since homozygous 12-day old SmD3 mutant lar-
vae show overgrowth of the brain, hematopoietic organs
and imaginal discs and die during third instar larval or
pupal stages [51]. Finally, we also identified staufen (stau),
which has been shown to be involved in the asymmetric
localization of cell fate determinants during neuroblast
divisions [52], as upregulated in neoplastic tissue.
Genes involved in chromatin structure, transcription/
replication/repair, and transcriptional regulation
In addition to the expected upregulation of genes
involved in cell cycle regulation as well as ribosome syn-
thesis and RNA processing, we also observed that the
basal transcriptional machinery was significantly upregu-
lated in the bratk06028 tumor condition (Figure 5). Within
the functional class chromatin structure we found 13 genes
with elevated expression levels. Among those are genes
involved in various aspects of chromatin modeling such
as Nucleoplasmin (Nlp), involved in nucleosome spacing,
and Nucleosome assembly protein 1 (Nap1) as well as Chro-
matin assembly factor 1 subunit (Caf1), both encoding pro-
teins with histone-specific chaperone activity [53]. We
also detected two suppressors of variegation, namely Sup-
pressor of variegation 3–9 (Su(var)3-9) with histone meth-
yltransferase activity [54] and Suppressor of variegation 205
(Su(var)205) involved in the establishment of chromatin
silencing. Interestingly, mutant analysis of Su(var)205
revealed that larval brain neuroblasts show cytokinesis
defects during mitosis [54]; this is also the case for gluon
(glu), which we detected as significantly upregulated in
the tumor condition. In glu mutants, larval brain neurob-
lasts show distinct abnormalities during chromosome
segregation and lethality occurs during the late larval stage
[55].
In the functional class transcription/replication/repair we
identified 20 genes as differentially regulated in the
bratk06028 tumor condition, all of them having elevated
expression levels as compared to wildtype. Among them
are the minichromosome maintenance (MCM) genes, which
encode an evolutionary conserved family of molecules
that form an important part of the pre-replicative
complex, required for DNA replication [56]. We found
two members of this complex (mcm2 and mcm3) as upreg-
ulated in bratk06028 neoplasms. Interestingly, Mcm2
mutants persist as third instar larvae for several days, and
dissection of wandering larvae demonstrates that their
CNS is smaller than that of wildtype and that they lack
identifiable imaginal discs [57]. We also detected muta-
gen-sensitive 209 (mus209), involved in mitotic spindle
assembly as upregulated. Mutants of mus209 show abnor-
mal chromosome condensation [58], whereas mutations
of rad50, a gene involved in DNA repair, result in elevated
levels of anaphase bridges in dividing cells of third instar
larval brain and imaginal discs. Moreover, RNA polymerase
II 15 kD subunit (RpII15), involved in transcription from
Pol II promoter [59] and absent, small or homeotic disc 2
(ash2), a member of the trithorax group were detected as
upregulated. Interestingly, mutant alleles for ash2 are lar-
val pupal lethals and display imaginal disc and brain
abnormalities [60].
Among the transcripts belonging to the functional class
transcriptional regulation, we identified two members of the
snail family of zinc-finger transcription factors, namely
worniu (wor) and snail (sna) as significantly upregulated in
bratk06028 neoplasms. During wildtype embryogenesis,
both genes are expressed during neuroblast delamination,
and mutant analyses suggest that Snail and Worniu func-
tion in neuroblasts, around the time of division to give
rise to ganglion mother cells (GMCs) [61]. Moreover, we
also detected upregulation of several other transcription
factors involved in the control of proliferative activity of
embryonic and postembryonic neuroblasts. Thus, we
identified tailless (tll), deadpan (dpn), and castor (cas) as
upregulated. tll is expressed in procephalic neuroblasts
and required for their specification as tll mutants lack the
anterior brain [62]. dpn encodes a pan-neural gene shown
to be expressed in all neuronal lineages during embryo-
genesis as well as in neuroblasts of the larval CNS and in
precursors of sensory neurons in imaginal discs. Loss- and
gain-of-function experiments suggest that dpn activity is
critical for the proper regulation of cell proliferation in the
larval brain [63]. cas is involved in a cascade of sequen-
tially expressed transcription factors, which translates
information on timing of GMC formation [64]. In addi-
tion, cas is known to be involved in post-embryonic brain
development as small homozygous somatic mutant cas
clones in the adult brain lead to ellipsoid body and mush-
room body defects [65]. Finally, we also detected diminu-
tive (dm), the Drosophila homolog of the proto-oncogene
c-myc, as significantly upregulated in the bratk06028 tumor
condition. Myc genes link patterning signals to cell
division by regulating primary targets involved in cellular
growth and metabolism [66].
Genes involved in cytoskeleton/structural and signal 
transduction
In previous studies, histological analysis of bratk06028
mutants indicated that the brain tumor phenotype is pri-
marily due to uncontrolled divisions of optic lobe neu-
roblasts and GMCs [33]. Our microarray expression
analysis supports the assumption that neuroblasts and/or
GMCs are at the cellular origin of these brain tumors. This
is not only evident by the significant upregulation of
genes involved in neuroblast delamination and
proliferation such as wor, sna, tll, dpn, and cas, but also by
the elevated transcription levels of specific genes belong-Page 9 of 22
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Differential expression of genes belonging to the functional classes chromatin structure, transcription / replication / repair, and 
transcriptional regulation. Fold-changes for each gene are shown in red for experiment A and in orange for experiment B, 
respectively.
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nal transduction (Figure 6).
In the functional class cytoskeleton/structural, we found
high levels of transcription in bratk06028 tumorous tissue
for the genes miranda (mira) and inscuteable (insc). This is
of particular interest, since both proteins play essential
roles in the asymmetric localization of cell fate determi-
nants during neuroblast divisions. Miranda creates intrin-
sic differences between sibling cells by mediating the
asymmetric segregation of transcription factor Prospero
into only one daughter cell during neural stem-cell divi-
sion. In insc mutants, mitotic spindles in neuroblasts fail
to rotate into proper position and neuroblasts divide in
random orientation resulting in general disorganization
of the neuroblast array and defective neuroblast morphol-
ogy (reviewed in [67]). Moreover, we also identified as
significantly upregulated in the tumor condition ciboulot
(cib), an actin binding protein, and the Drosophila profilin
protein chickadee (chic), both of which cooperate in cen-
tral brain metamorphosis [68]. Intriguingly, expression of
big brain (bib) appears to be downregulated in the
bratk06028 tumor condition. bib encodes a product with
connexon channel activity, which is required autono-
mously in epidermal precursors to prevent neural devel-
opment (reviewed in [69]).
Differential expression of genes belonging to the functional classes cytoskeletal / structural and signal transductionFigu  6
Differential expression of genes belonging to the functional classes cytoskeletal / structural and signal transduction. Fold-
changes for each gene are shown in red for experiment A and in orange for experiment B, respectively.
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signal transduction, we identified several members of
GTPase signal transduction pathways as significantly
upregulated in bratk06028 neoplasms. Thus, we identified
RacGAP50C, which has GTPase activator activity and is
involved in Rho protein signal transduction, and also
three members of the Ran GTPase signal transduction
pathway, namely Segregation distorter (Sd), ran, and mole-
skin (msk). Moleskin, for example, appears to be involved
in EGF receptor signalling pathway initiation of gene
expression in response to Drosophila receptor tyrosine
kinase signalling [70]. We also detected MAP kinase acti-
vated protein-kinase-2 (MAPk-Ak2), which has protein ser-
ine/threonine kinase activity, as significantly upregulated.
In addition, we identified Notch (N) as significantly
upregulated in the bratk06028 tumor condition. Notch
encodes a transmembrane receptor mediating cell-cell
communication, and Notch signalling has been impli-
cated in a wide variety of cellular processes, including the
maintenance of stem cells, specification of cell fate, differ-
entiation, and proliferation [71]. Surprisingly, however,
the Insulin-related peptide (Ilp2), a component of the insu-
lin signalling pathway, was downregulated in the tumor
condition. Overexpression of Ilp2 alters growth control in
a Insulin receptor-dependent manner, suggesting a role
for Ilp2 in controlling organismal size by augmenting
both cell number and cell size of different organs
(reviewed in [66]).
Genes involved in cell surface receptors/CAMs, 
chaperones, proteolytic systems, stress response and 
transport
Previous studies have shown that tumor cells derived
from homozygous brat larval brain tissue can grow not
only in situ, but also after transplantation into adult host
flies. The transplanted cells grow rapidly, forming metas-
tases and secondary malignant tumors that finally kill
their host [34]. This suggests that loss of brat leads to the
acquisition of invasive and metastatic properties of the
resulting tumor cells. This acquisition of invasive and
metastatic abilities is associated with altered binding
specificities of cell adhesion molecules (CAMs), the
activation of proteases, as well as chaperones and heat
shock proteins mediating stress response [1,72]. In
accordance with this, our transcriptional analysis of
bratk06028 tumor cells identified genes as differentially reg-
ulated in the tumor condition belonging to the functional
classes cell surface receptors/CAMs, chaperones, proteolytic sys-
tems, and stress response (Figure 7). Within the class cell sur-
face receptors/CAMs we identified Neurotactin (Nrt), a
transmembrane protein that localizes to cell-cell junc-
tions where it mediates cell adhesion and cell signalling,
as upregulated [73]. Three other genes belonging to the
class cell surface receptors/CAMs were differentially down-
regulated in the bratk06028 tumor condition. Among the
classes proteolytic systems, chaperones and stress response, we
identified genes upregulated like Ubiquitin carboxy-termi-
nal hydrolase (Uch), involved in protein deubiquitination,
and granny smith with leucyl aminopeptidase activity. Also
the chaperones T-complex Chaperonin 5 (Cct5) and Cct-
gamma with chaperonin ATPase activity involved in pro-
tein folding and the heat shock proteins Hsp27, Hsp26,
and Hsc70-4 were identified as significantly upregulated
in the bratk06028 tumor condition. Finally, we detected 10
transcripts belonging to the functional class transport as
differentially regulated in neoplastic bratk06028 tissue.
Among these is Pendulin (Pen), an adaptor molecule
which is expressed in embryonic neuroblasts and the pro-
liferating regions of the larval brain lobes and may be
required for the normal transmission and function of pro-
liferative signals in the cells [74].
Vertebrate homologs of genes differentially regulated in 
bratk06028 neoplasms are involved in mammalian cancer 
formation
Our analysis of the 321 genes differentially regulated in
bratk06028 neoplasms revealed genes involved in general
aspects of tumorigenesis such as elevated and aberrant
metabolic activity, elevated and aberrant activity of the
cell cycle and basal transcriptional machinery, as well as
elevated and aberrant activity of ribosome synthesis and
translation control. Considering the level of gene and
pathway conservation, the similarity of cellular processes,
and the emerging evidence of functional conservation of
Drosophila genes that are homologous to mammalian
oncogenes or tumor suppressor genes [16,17], we won-
dered whether our data might reveal any parallels to the
genetic alterations associated with mammalian cancer for-
mation. This is of particular interest since one of the two
human homologs of brat, TRIM3, has been mapped to
chromosome 11p15 [75,76], a region that has been
termed the "multiple tumor-associated chromosomal
region 1" due to the presence of numerous cancer-related
genes in this region [77,78].
We therefore searched available databases in order to
identify vertebrate homologs of the 321 genes differen-
tially regulated in bratk06028 neoplasms and to determine
their possible involvement in mammalian cancer forma-
tion. We identified 62 out of 321 Drosophila genes as hav-
ing mammalian homologs, of which misregulation has
been associated with various types of tumors (see Table
2). Mammalian homologs of genes involved in the regu-
lation of conserved aspects of cell proliferation were
found to be implicated in mammalian cancer formation.
Among these are mammalian homologs of cyclins, Cdks,
and genes involved in various other aspects of cytokinesis
and the maintenance of genomic integrity. Thus, the string
homolog Cdc25B, encoding a dual-specific phosphatase
that mediates cell cycle progression by activating cyclin-Page 12 of 22
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potential and is frequently overexpressed in human pros-
tate cancer tissues [79]. Drosophila CG9993 encodes for a
long-chain fatty acid transporter and its rat homolog
(FATP) shows elevated transcript levels in hepatoma cell
lines [80]. Homologs of Drosophila MCM family of pro-
teins are known as proliferation markers in vertebrates,
and evidence exists that HsMCM2 is upregulated in pri-
mary human tumor tissue [81]. Furthermore, it has been
shown that the rate and level of Mcm3 and MCM4 expres-
Differential expression of genes belonging to the functional classes cell surface receptors /CAMs, chaperones, proteolytic sys-tems, stress response, and transportFigu  7
Differential expression of genes belonging to the functional classes cell surface receptors /CAMs, chaperones, proteolytic sys-
tems, stress response, and transport. Fold-changes for each gene are shown in red for experiment A and in orange for experi-
ment B, respectively.
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proliferating cells of the uterine cervix and dysplastic cells.
Prominent examples of genes involved in mammalian
cancer formation are the proto-oncogenes Myb and Myc.
The Myc gene is a central regulator of proliferation, differ-
entiation, cell survival, and neoplastic transformation. It
is found mutated or overexpressed in up to 30% of human
cancers and the Myc network appears to regulate a large
number of genes, approaching 10% of human genes [82].
Similarly, the human homolog of Drosophila CG9772,
called SCFSkp2, is an ubiquitin ligase encoding onco-pro-
Differential expression of genes belonging to the functional class unknown functionFigu  8
Differential expression of genes belonging to the functional class unknown function. Fold-changes for each gene are shown in 
red for experiment A and in orange for experiment B, respectively.
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BMC Genomics 2004, 5 http://www.biomedcentral.com/1471-2164/5/24Table 2: Drosophila genes differentially regulated in bratk06028 neoplastic tissue and their mammalian homologs shown to be involved in 
cancer formation.
Fly gene Mammalian homolog Cancertype
CG17498 HsMAD2L1 breast cancer
CycE HsCCNE1 breast cancer
MAPk-Ak2 HsMAPKAPK2 breast cancer
Ent2 HsSLC29A1 breast cancer
CG6546 HsBAF53A breast cancer
FK506-bp1 HsFK506-bp1 childhood astrocytoma
cib HsTMSB4X colon cancer
UTPase HsDUT colorectal
Ef1gamma HsEEF1G colorectal adenoma
Aats-ile HsIARS colorectal cancer
msk HsIPO7 colorectal cancer
CG8235 HsSCYE1 fibrosarcoma, melanoma
Bub3 HsBUB3 gastric cancer
Myb MmMYB glioma
CG5525 HsCCT4 hepatocelluar and colonic carcinoma
cdc2 HsCDC2 hepatocellular cancer
Lam HsLMNB1 hepatocellular cancer
CG9993 MmFATP hepatoma 7288CTC
CG31232 HsCCNK Karposi sarcoma
Aats-his HsHARS laryngeal epithelial carcinoma
ash2 HsASH2L leukemia
und HsMetAP2 leukemia
GTP-bp HsSRPR leukemia
N HsNotch2 lung cancer, leukemia
Dpit47 HsTTC4 melanoma
nop5 HsNOP5/NOP58 melanoma
btd HsEGR1 melanoma, prostate cancer
Jafrac2 HsPRDX4 mesothelioma
Nup98 HsNUP98 myeloid leukemia
Rm62 HsDDX5 ovarian cancer
fzy HsCDC20 pancreatic cancer
mfas HsTGFBI pancreatic cancer
CG15000 HsNAB1 prostate cancer
Hsp27 HsHSPB2 prostate cancer
CG8142 HsRFC4 prostate cancer
ran HsRAN prostate cancer
Ef1alpha48D HsEEF1A1 prostate cancer
tll MmNr2f1 retinoblastoma
Ercc1 HsERCC1 squamous cell carcinoma of the head and neck
CkIIbeta HsCSNK2B squamous cell carcinoma of the head and neck
GstE1 HsGSTT1 thyroid cancer
Mipp1 HsMINPP1 thyroid cancer
CG9344 HsSNRPF uterine cancer
RnrS HsRRM2 uterine cancer
SmD3 HsSNRPD3 uterine cancer
Mcm3 HsMCM3 uterine cervical carcinoma
polo HsPLK various
Cyclin A HsCCNA1 various
Mcm2 HsMCM2 various
Klp61F HsKIF11 various
mus209 HsPCNA various
CG9772 HsSKP2 various
Fib HsFBL various
stg HsCDC25B variousPage 15 of 22
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to control Myc levels through the ubiquitin pathway.
Interestingly, this ubiquitin ligase is also required for
induction of Myc-responsive genes, suggesting that ubiq-
uitination not only promotes Myc turnover but also
"licenses" its transcriptional activity [83]. Examples of
homologous genes involved in human brain tumor for-
mation are the tailless ortholog Nr2f1 involved in
retinoblastoma, and the homologs of Myb (MYB), dm
(MYC), and Notch (NOTCH2), whose misregulation has
been associated with human gliomas [71,84].
Discussion
A core transcriptional signature of neoplastic brain tissue 
in Drosophila
In order to gain insights into the transcriptional altera-
tions associated with brain tumors in vivo, we have deter-
mined the transcriptional signature of an adult brain
tumor in Drosophila caused by homozygous mutation in
the tumor suppressor gene brat. To this end, we have
conducted two independent genome-wide gene expres-
sion studies using two different oligonucleotide microar-
ray platforms to compare adult wildtype flies with flies
displaying the adult bratk06028 mutant brain tumor. Cross-
validation of our comparative analysis of adult wildtype
heads compared to bratk06028 heads versus dissected
bratk06028 brains compared to dissected adult brains of flies
generated by transposon excision of the bratk06028 P-ele-
ment identified a core transcriptional signature of
bratk06028 neoplastic tissue. The obtained transcriptional
signature revealed genetic alterations associated with
malignant growth in a highly reproducible manner,
despite the fact that both the biological material and the
array platforms used differed considerably between the
two experiments. This involved the use of stringent filter
criteria such as a significance value of p ≤ 0.0001 (t-test).
Due to these very stringent filter criteria, the 321 tran-
scripts detected as differentially regulated in the bratk06028
tumor condition probably represent only a subset of
genes that could be involved in brain tumorigenesis. For
example, it has been shown that PTEN plays a crucial role
in the highly conserved insulin/PI3-kinase (PI3K) signal-
ing pathway involved in cell growth and proliferation (for
review see [66] and the human homolog of PTEN is
frequently lost in gliomas (reviewed in [84]). Although we
did detect PTEN as differentially down-regulated in the
brat tumor condition in both experiments, it was not
incorporated into the core set of genes differentially regu-
lated in bratk06028 neoplasms due to p-values below our
cutoff value (see supplementary material).
Nevertheless, our genome-wide microarray analysis in
Drosophila identified characteristic features of malignant
growth such as those found in human cancer. Thus, we
detected gene expression changes indicative of elevated
and aberrant metabolic activity, elevated and aberrant
activity of the cell cycle and basal transcriptional
machinery, and elevated and aberrant activity of ribosome
synthesis and translation control associated with the adult
bratk06028 mutant brain tumor. Our data are in accordance
with assumptions that the vast catalog of cancer cell gen-
otypes is a manifestation of essential alterations in cell
physiology that collectively dictate malignant growth:
self-sufficiency in growth signals, insensitivity to growth-
inhibitory (antigrowth) signals, evasion of programmed
cell death (apoptosis), limitless replicative potential, and
tissue invasion and metastasis [1]. This is further
exemplified by the fact that for 20% of the genes
differentially regulated in the Drosophila bratk06028 tumor
condition it was possible to identify mammalian
homologs associated with various types of tumors. These
include homologs of Myb, Myc, cyclins as well as other
genes involved in cell growth and proliferation control
whose misregulation is frequently associated with mam-
malian cancer formation and malignant growth [1].
Brat acts as a tumor suppressor during Drosophila brain 
development
Brat was originally identified as a growth suppressor of the
larval brain of Drosophila, with mutant brains growing up
CycB HsCCNB1 various
Cdk7 HsCDK7 various
eEF1delta HsEEF1D various
crc HsATF4 various
CG8586 HsKLKB1 various
betaTub60D HsTUBB2 various
BM-40/SPARC HsSPARC various
dm HsMYC various
Drosophila genes differentially regulated in bratk06028 neoplastic tissue and their mammalian homologs shown to be involved in cancer formation. 
Indicated are the Drosophila genes, their human (Homo sapiens, Hs) or mouse (Mus musculus, Mm) homolog, and the cancer type for which 
misregulation of the mammalian homolog has been reported in available databases like Flybase and PubMed. References are given in the 
supplementary material (References for table 2) [see Additional file 5].
Table 2: Drosophila genes differentially regulated in bratk06028 neoplastic tissue and their mammalian homologs shown to be involved in 
cancer formation. (Continued)Page 16 of 22
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conferred metastatic potential upon tissues transplanted
into wildtype host flies [34]. Moreover, our analysis of the
bratk06028 allele shows that a substantial amount (15%) of
homozygous mutant flies eclose and show a strong neo-
plastic adult brain phenotype with 100% penetrance.
These data demonstrate that Brat functions as a tumor
suppressor during brain development of Drosophila.
In general, tumor suppressors act as molecular antagonists
to the formation of malignancy, a physiological state that
is characterized by indefinite cellular growth and division
[1]. This in turn requires elevated levels of transcriptional
activity of genes involved in all aspects of aberrant cell
cycle activity. Indeed, our genome-wide microarray
expression analysis of bratk06028 neoplastic tissue revealed
genetic alterations that can be attributed to malignant
growth. We identified essential components of the cell
cycle machinery like cyclin A, B, E, string and Myb as signif-
icantly upregulated in the tumor condition. This elevated
cell cycle activity is accompanied by significant upregula-
tion of genes involved in DNA replication, chromatin
structure and cytokinesis, such as gluon, Mcm2 and Mcm3,
and the Drosophila Myc homolog diminutive. Gain of func-
tion of these genes is frequently associated with malignant
overgrowth and cancer in Drosophila [16]. Moreover,
deregulation of the proto-oncogenes Myb and Myc charac-
terizes one of the hallmarks of cancer, as the oncogenic
activity of these genes in turn impairs differentiation and
promotes growth [66]. In addition, we also observed sig-
nificant upregulation of the Ran GTPase pathway since
three members of it, namely Sd, ran, and msk, show ele-
vated expression levels in the bratk06028 tumor condition.
Recent data suggest that Ran GTPase signalling serves as a
positional marker for the eukaryotic genome throughout
the cell cycle by regulating microtubule nucleation and
nuclear envelope formation around chromatin (reviewed
in [85]). This together with the elevated and aberrant
activity of several other structural components required
for proliferation and cytokinesis emphasises the self-suffi-
ciency of the cellular machinery during unrestrained
growth.
Proliferation control via ribosome synthesis regulation by 
brat?
Recent results demonstrate that brat functions to repress
ribosomal RNA synthesis and cell growth. brat mutant
cells are larger than control cells, have enlarged nucleoli
and contain excess rRNA. Furthermore, brat overexpres-
sion inhibits clone and organ growth, and leads to a
decreased level of rRNA per cell [30]. Based on these
observations it has been suggested, that in contrast to the
cell growth regulation pathway of the insulin receptor and
its effectors, brat affects cell growth not through the activ-
ity of ribosomes, but rather through the regulation of their
synthesis [30]. Indeed, disruption of one or more of the
steps that control protein synthesis has been associated
with alterations in the cell cycle and regulation of cell
growth. For example mutations that inactivate the tumor-
suppressor activity of RB or p53, or both, result in aberrant
upregulation of essential components in the protein syn-
thesis machinery and increase ribosome biogenesis, lead-
ing to enhanced mRNA translation rates (reviewed in
[86]). Among the 321 genes differentially regulated due to
loss of the tumor suppressor activity of brat, we identified
several genes involved in ribosome biogenesis and RNA
processing as significantly upregulated in neoplastic tis-
sue. One of the most prominent examples is ribosomal
protein RpL3 which maps to the chromosomal region
harbouring the Minute(3) 86D mutation [48]. However,
although we observe several genes involved in protein
synthesis and ribosome biogenesis as differentially upreg-
ulated in the bratk06028 tumor condition, it remains to be
determined whether these phenomena represent the
cause or consequence of tumor formation.
Neuroblast polarity and asymmetric division
Interestingly, we find that inscuteable (insc), staufen (stau),
snail (sna), miranda (mira), and worniu (wor) have elevated
transcript levels in bratk06028 brain tissue. Both insc and
stau are involved in asymmetric segregation of cell fate
determinants in dividing neuroblasts and insc expression
is thought to be regulated by sna [52,61]. Miranda is an
adaptor protein involved in the distrinution of the Pros-
pero gene product. Prospero is required to distinguish the
proliferative capabilities of NBs and GMCs [67]. As it is
known that the Discs large (Dlg), Scribble (Scrib) and Lethal
giant larvae (Lgl) tumor suppressor proteins regulate mul-
tiple aspects of neuroblast asymmetric cell division these
findings strengthen the link between tumorigenesis and
asymmetry in cell division [87].
Conclusions
Taken together, our genome-wide microarray expression
analysis of an adult brain tumor in Drosophila caused by
mutation in the tumor suppressor gene brat identifies a
core set of genes whose deregulation can be attributed to
the genetic alterations associated with tumor formation
and malignant growth. We detect aberrant and elevated
activity in the transcription of genes involved in metabolic
activity, cell cycle regulation, cytokinesis, as well as in
basal transcriptional regulation. 20% of the genes we
identified as differentially regulated in the bratk06028 tumor
condition have mammalian homologs whose misregula-
tion has been associated with various types of tumors.
Moreover, we observed significant alterations in
transcriptional activity of genes involved in ribosome bio-
genesis, translation and RNA processing due to loss of the
translational repressor encoded by brat. This may indicate
that loss of brat leads to overexpression of ribosomal pro-Page 17 of 22
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cause malignant growth. Considering the evolutionary
conservation of gene structure and function, we propose
that our results obtained by the first genome-wide expres-
sion analysis of an adult brain tumor in Drosophila will
also be valid for tumor formation in mammals. It will
now be important to elucidate at the cellular and molecu-
lar level the mechanisms involved in the genetic altera-
tions caused by mutation of the tumor suppressor brat,
which ultimately lead to tumor formation, metastasis and
invasiveness.
Methods
Fly strains and genetics
The wildtype was Oregon R. The brat allele used in this
study is bratk06028, balanced over CyO, P{w+mc = Act-
GFP}JMR1. Flies used for histology and for transcript pro-
filing were 1 to 2 days old homozygous P{w+mc = lacW},
bratk06028 males and females, identified by the absence of
GFP. For the control condition of the oligonucleotide
array experiment, either wildtype Oregon R were used or
flies generated by transposon excision of the k bratk06028 P-
element. Excision of the bratk06028 transposon resulted in
several viable strains, which were further characterized by
genomic PCR. Using the primer pair 5'AACAAC-
CAAAACAACGGCAACC 3' and 5' AAACGGAGA-
TAAGCCGACTTAC 3', flanking the insertion site of the
bratk06028 transposon in the brat genomic DNA, a fragment
of 211 bp was PCR amplified and sequenced from both
strands. For all characterized strains, this sequence was
indistinguishable from the genomic brat sequence of Ore-
gon R control flies; strain "bratk06028 jumpout" was chosen
for further work. For assessing the percentage of adult
escapers in bratk06028, homozygous third instar larvae were
identified by the absence of GFP, counted (n = 979) and
collected into bottles containing standard food. Bottles
were then subsequently checked on a daily basis for
hatched flies during the following 4 weeks. All flies were
kept on standard cornmeal/ yeast/ agar medium at 25°C.
Histology
For sectioning, adult flies were fixed, dehydrated, embed-
ded in paraffin, and cut into 7 µm sections as described by
Heisenberg and Böhl [88]. Sections were mounted on
coated glass slides with DePeX (Fluka), and neural struc-
tures were visualized with a Zeiss Axioskop microscope by
autofluorescence (wavelength 488 nm) and recorded
using a Prog/Res/3008 digital camera (Kontron, Zürich).
Experimental paradigms and oligonucleotide arrays
Two oligonucleotide array experiments were carried out.
In the first experiment, a custom-designed Drosophila oli-
gonucleotide array (roDROMEGAa, Affymetrix) was used
[89]. This array contains 14,090 sequences representing
13,369 single transcripts encoding Drosophila proteins
deposited in SWISS-PROT/TrEMBL databases (Celera
Genome/BDGP Release no.1; [10] as well as prokaryotic
and custom chosen control sequences. This array was used
to compare the transcriptome from Oregon R control
heads with heads of homozygous bratk06028 flies; 5 repli-
cates were done for the wildtype condition and 6 were
done for homozygous bratk06028 (experiment A). In the
second experiment, a commercially available Affymetrix
Drosophila full genome array was used (Drosophila
Genome Array, Affymetrix) which contains probe sets
interrogating more than 13,500 genes from Drosophila
melanogaster (experiment B). Sequences used to design
this array can be found in Flybase (version 1). Over 8,000
of the genes represented have at least one EST/cDNA
match. Additionally, approximately 5,500 genes were
identified using prediction algorithms. This array was
used to compare the transcriptome of dissected Drosophila
brains derived from bratk06028 jumpout with that of
homozygous bratk06028 brains. 6 replicates were done for
each of the two conditions.
Preparation of biotinylated cRNA
Total RNA was isolated from 100 fly heads or 150 fly
brains, respectively, using guanidinium isothiocyanate in
combination with acidic phenol (pH 4.3) (fast RNA tube
green kit from BIO101) in a fast prep homogenizer FP120
(Bio 101). After precipitation, RNA was dissolved in
DEPC-treated water (Ambion) and spectrophotometri-
cally quantified using a GeneQuant RNA/DNA calculator
(Pharmacia Biotech). The quality of the RNA was checked
on a 0.5 × TBE agarose gel and the samples were stored at
-80°C. cDNA was synthesized upon total RNA as a
template, using the SuperScript Choice System for cDNA
synthesis (Gibco/BRL) with a T7-(T)24 DNA primer. This
primer (5'-GGCCAGTGAATTGTAATACGACTCACTAT-
AGGGAGGCGG-(T)24VN-3') was PAGE-gel purified. For
first strand cDNA synthesis, a typical 40 µl reaction con-
tained 10–15 µg RNA, 200 pmoles T7-(T)24 primer, 500
µM of each dNTPs and 800 units reverse transcriptase
(AMV Superscript II). The reaction was incubated for one
hour at 42°C. Second strand cDNA synthesis was carried
out at 18°C for two hours in a total volume of 340 µl,
using 20 units E. coli DNA ligase, 80 units E. coli DNA
polymerase I and 4 units RNase H in the presence of 250
µM of each dNTP. After 2nd strand cDNA synthesis, 0.5 µl
RNase A (100 mg/ml) (Qiagen) was added and the sam-
ples were incubated at 37°C for half an hour. Thereafter
7.5 µl proteinase K (10 mg/ml) (Sigma) was added and
the samples were further incubated at 37°C another half
hour. After cDNA synthesis was completed, samples were
phenol-chloroform extracted (3 times) using Phase Lock
Gel (5 Prime-3 Prime, Inc.) and precipitated overnight at
-20°C with 2.5 volumes 100 % ethanol. After percipita-
tion, the samples were stored at -20°C. Biotinylated anti-
sense cRNA was synthesized from the dsDNA template,Page 18 of 22
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A 20 µl reaction volume contained between 0.3–1.5 µg
cDNA, 7.5 mM of both ATP and GTP, 5.6 mM of both
UTP and CTP and 1.8 mM of both biotinylated Bio-16-
UTP and Bio-11-CTP (ENZO diagnostics) and 2 µl 10 × T7
enzyme mix. The reaction was incubated at 37°C for 8
hours. Thereafter the unincorporated NTPs were removed
by putting the sample over an RNeasy spin column (Qia-
gen). Aliquots of the reaction before and after cRNA syn-
thesis were analyzed by agarose gel electrophoresis.
Samples were precipitated overnight at -20°C, taken up in
20 µl DEPC treated water and spectrophotometrically
quantified. Susequently, the biotinylated antisense cRNA
was fragmented by heating the sample to 95°C for 35 min
in a volume of 25 µl, containing 40 mM tris-acetate (pH
8.1), 100 mM KOAc, 30 mM MgOAc. After the fragmenta-
tion, the samples were placed on ice.
Hybridization and Scanning
Gene chips were equilibrated at RT and prehybridized
with 280 µl hybridization buffer (1 × MES (pH 6.7)/ 1 M
NaCl/ 20 mM EDTA/ 0.01 % Tween 20) for 15 min at
45°C with rotation at 60 rpm. Hybridization was done for
16 h at 45°C (60 rpm) in a final volume of 220 µl hybrid-
ization buffer, 0.1 mg/ml herring sperm DNA, 0.5 mg/ml
acetylated BSA containing 50 pM control oligo B2, spiked
bacterial control RNAs (BioB, BioC, BioD, cre) and 15 µg
fragmented biotinylated cRNA. After hybridization, the
arrays were briefly rinsed with 6 × SSPE-T buffer (0.9 M
NaCl/ 0.06 M NaH2PO4/ 6 mM EDTA/ 0.01 %Tween 20).
Washing and staining were carried out on a Fluidics sta-
tion 400 (Affymetrix, MAS 5.0) using 100 mM MES, 0.1 M
NaCl, 0,01 % Tween 20 as stringent wash buffer. Two dif-
ferent staining protocols were used. When comparing the
transcriptome of Oregon R fly heads and homozygous
bratk06028 fly heads, staining was carried out in 220 µl 1 ×
MES buffer, 2.0 mg/ml acetylated BSA, 10 ng/ ml Strepta-
vidinR-phycoerythrin conjugate (Molecular Probes) at
40°C for 15 min. In the second experiment comparing
dissected brains of bratk06028 jumpout flies with
homozygous bratk06028 brains, an additional antibody
amplification step was included. Prior to staining, 220 µl
1 × MES buffer containing 2 mg/ml acetylated BSA and 2
µg/ml biotinylated anti-streptavidin antibody (Vector)
was applied onto the array for 30 min at 40°C. Following
a washing step, staining was then performed using strepta-
vidinR-phycoerythrin as described above. Following a
final washing step, arrays were scanned with a commercial
confocal laser scanner (Agilent).
Data analysis
The single arrays were analysed using Microarray Suite 5.0
(Affymetrix). Detailed analysis was carried out using Race-
A (Roche), Excel2000 and Access2000 software (Micro-
soft), and GeneSpring (Silicon Genetics). In this process,
the mean of all signal values of each array were set to 1,
and all other signal values were expressed relative to it
(normalization). A Nalimov outlier test was performed
[90]. The data was grouped into control- and experimen-
tal conditions. For every gene in all 4 conditions a single
mean signal value over the replicates was calculated. Also
an unpaired t-test was performed for every gene per exper-
iment to assess significance of change between condi-
tions. The annotation of the two different arrays was
linked (see below) using information from NetAffx [91]
and Flybase [92]. Genes were judged as present when their
presence attribute in the RACE-A software was above 0.75.
Both datasets were filtered using a cutoff on the mean sig-
nal (≥ 10 in the condition the gene had to be present in),
the changefold (≥ 2) and the t-test (≤ 0.0001). The various
control sequences present on the arrays were excluded
from analysis. Subsequently the overlap of the two data-
sets was calculated using the database mentioned above.
When more than one probe set was representing a gene
the probe set with the highest statistical significance as
judged by the t-test was chosen. In those cases were the p-
value was identical, the probe set with the higher expres-
sion levels was chosen. The raw data of the two experi-
ments can be found in Supplementary Table 1 and
Supplementary Table 2 [see Additional files 1 and 2].
Linking the two different oligonucleotide arrays
Using the probe set annotation information provided for
the roDROMEGa array, we determined which probe sets
on the Affymetrix "DrosGenome1" GeneChip were
analogous to those on the Roche custom chip. To this end,
a database was built with the following information: 1)
Affymetrix "DrosGenome1" probe set annotations, 2)
roDROMEGa annotations, and 3) FlyBase gene
annotations.
The Affymetrix "DrosGenome1" annotations were
extracted from the June 2003
DrosGenome1_annot_csv.zip file obtained from the
NetAffx [91] Affymetrix web site http://www.affyme
trix.com/Auth/analysis/
downloadtaDrosGenome1_annot_csv.zip. The database
tables contained probe set ID, gene symbol, FlyBase
FBgns, and synonyms as annotated by Affymetrix for each
of the 14,010 probe sets on DrosGenome1. The
roDROMEGa array annotations were extracted from text
dump files obtained from Roche. The database table con-
tained probe set ID and gene symbol information for each
of the 14,090 probe sets on the Roche custom chip. Fly-
Base gene annotations were extracted from the 29-08-
2003 FlyBase genes dump file located at ftp://flybase.org/
flybase/genes/genes.txt. The resulting database tables con-
tained gene symbol, FBgns, and synonyms for all 43,177Page 19 of 22
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DrosGenome1 and FlyBase annotations from their source
files, special cleanup was required to correct from HTML
escape characters commonly used in Drosophila mela-
nogaster annotation dump files. This was necessary
because the annotations for the roDROMEGa array con-
tained only fully spelled out words for gene symbols (i.e.
'alphaCop' instead of '&agr;Cop').
The 14,090 probe sets on the Roche custom Drosophila
microarray represented 13,343 distinct genes which were
mapped to Affymetrix's DrosGenome1. Utilizing the data-
base described above, we first mapped gene symbols
annotated by Roche on their custom chip to gene symbols
and synonyms annotated by Affymetrix on their
DrosGenome1 chip. This search yielded 13,377 probe sets
(12,784 genes) on the Roche Drosophila custom chip. The
remaining 713 probe sets on the Roche custom chip
which had no direct gene symbol or synonym match to
DrosGenome1 were used in a three-way search using
FlyBase genes data. These 713 Roche gene symbols were
searched against all FlyBase gene symbols and synonyms
and in case of a match all the corresponding FlyBase
FBgns for these genes were used to search the Affymetrix
FBgn annotations on DrosGenome1. This search resulted
in additional 449 probe sets (401 genes) on the Roche
Drosophila custom chip which mapped to analogous
probe sets on DrosGenome1. Of the remaining 172
unmapped Roche probe sets, 92 were found to be either
Affymetrix AFFX controls, Roche internal controls, or
rRNA controls. Thus, 13,826 Roche probe sets (13,185
genes) have at least one analogous Affymetrix
DrosGenome1 probe set. 172 probe sets (157 genes) on
the Roche Drosophila custom chip dolfed our parameters
and remained orphaned with no Affymetrix
DrosGenome1 match. A list with the orphaned probe sets
can be found in Supplementay Table 4 [see Additional file
4]
Functional classification and links to mammalian 
homologs involved in cancer
The 321 genes differentially regulated in both experiments
were grouped into functional classes by reviewing their
annotation in Flybase. When there were vertebrate
homologs annotated in Flybase we searched the PubMed
bibliographic database http://www.ncbi.nlm.nih.gov/
PubMed/medline.html for literature that linked the gene
in question to cancer in vertebrates.
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